NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics

Dr. Botond Roska says we should keep our eyes on gene therapy.

Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

A Q&A with Bryan Laffitte, who leads a Novartis team that’s using the tools of genetic medicine to innovate new therapies for neuromuscular and neurodegenerative conditions.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.

Researchers around the world are collaborating to provide solutions to immediate and future challenges.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.